SCHEMBL713653

SCHEMBL713653

O=C(O)C(Br)=C(Br)C(=O)O

nearest known ligand 0.36

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA9 Q16790 1/20 0.36
LDHA P00338 1/20 0.36
LDHB P07195 1/20 0.36
TSHR P16473 1/20 0.33
ALDH1A1 P00352 1/20 0.33
THRB P10828 1/20 0.33
RECQL P46063 1/20 0.33
CYP2C19 P33261 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
ACHE P22303 1/20 0.31
FFAR3 O14843 1/20 0.31
LCK P06239 1/20 0.31
FYN P06241 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL713652 1.00 CA1 (0.36) CA1CA2CA9LDHALDHB
SCHEMBL10942185 1.00 CA1 (0.36) CA1CA2CA9LDHALDHB
Hydrochloric Acid SCHEMBL9621809 0.95 LDHA (0.33) CA1CA2CA9LDHALDHB
SCHEMBL27558779 0.95 LDHA (0.33) CA1CA2CA9LDHALDHB
SCHEMBL1405628 0.82
SCHEMBL6915265 0.79
SCHEMBL10525163 0.79
SCHEMBL6912785 0.79
SCHEMBL6909683 0.79
SCHEMBL6913983 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 224 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114247873-B Storage battery casting flux and method for preparing same 浙江平湖华龙实业股份有限公司 2023-03-17 CN claimed
CN-114247873-A Storage battery casting flux and method for preparing same 浙江平湖华龙实业股份有限公司 2022-03-29 CN claimed
US-20210167359-A1 ULTRATHIN LITHIUM COMPOSITE AND PREPARATION METHOD AND USE THEREOF INSTITUTE OF CHEMISTRY, CHINESE ACADEMY OF SCIENCES (CN) 2021-06-03 US claimed
EP-1747059-A1 PERVAPORATION COMPOSITE MEMBRANES McMaster University (CA) 2007-01-31 EP claimed
US-6989052-B1 Phase change ink printing process XEROX CORPORATION (US) 2006-01-24 US claimed
US-20060004123-A1 PHASE CHANGE INK PRINTING PROCESS XEROX CORPORATION 2006-01-05 US claimed
US-20060000778-A1 high-performance membrane designed for the selective removal of a polar fluid (water) from less polar fluids (organic solvents), by a pervaporation using a composite membrane contaiing ultrafiltration membrane as support ( e.g. cellulose acetate) and a crosslinked copolymer of anionic, cationic monomers MCMASTER UNIVERSITY (CA) 2006-01-05 US claimed
WO-2005102503-A1 PERVAPORATION COMPOSITE MEMBRANES MCMASTER UNIVERSITY (CA) 2005-11-03 WO claimed
US-6946025-B2 Process for preparing tetra-amide compounds XEROX CORPORATION (US) 2005-09-20 US claimed
US-20050090690-A1 Process for preparing tetra-amide compounds XEROX CORPORATION 2005-04-28 US claimed
US-4327197-A Fire-retardant anhydride copolymers ATLANTIC RICHFIELD COMPANY (US) 1982-04-27 US claimed
US-4323655-A Rubber-modified fire-retardant anhydride copolymers ATLANTIC RICHFIELD COMPANY (US) 1982-04-06 US claimed
US-4304874-A Fire-retardant anhydride copolymers ARCO POLYMERS, INC. (US) 1981-12-08 US claimed
US-4298705-A Rubber-modified fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-11-03 US claimed
US-4298703-A Fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-11-03 US claimed
US-4278768-A Rubber-modified fire-retardant anhydride copolymers ARCO POLYMERS, INC. (US) 1981-07-14 US claimed
US-4266037-A Fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-05-05 US claimed
US-4266038-A Rubber-modified fire-retardant imide copolymers ARCO POLYMERS, INC. (US) 1981-05-05 US claimed
US-12528973-B2 Composition and method for silicon oxide and carbon doped silicon oxide CMP CMC MATERIALS LLC (US) 2026-01-20 US disclosed
US-3951588-A Process for dyeing and printing or optical brightening of cellulose materials CIBA-GEIGY CORPORATION (US) 1976-04-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528973-B2 Composition and method for silicon oxide and carbon doped silicon oxide CMP PIEZO1, OCIAD2, CLK2 CA1 102/4885CA2 144/4885CA9 318/4885
US-20050090690-A1 Process for preparing tetra-amide compounds TAF9, TAF5, TAF1 CA1 139/4885CA2 664/4885CA9 20/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.